Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benfotiamine supplementation and vascular/AGE biomarkers in type 1 diabetes
2004-000799-15Phase 2Active
- Sponsor
- Aker Hospital
- Start
- Jun 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of benfotiamine in diabetes mellitus type 1 (T1D), sponsored by Aker Hospital. Primary endpoints: Serum advanced glycation end products, Biochemical markers of vascular dysfunction and 1 more. Started Jun 2004; status: active.
02
Drugs
benfotiamine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2004-000799-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000799-15.